
This actively managed exchange-traded fund (ETF) from GMO aims to primarily allocate its investments to company stocks outside the United States. These international equity holdings are drawn from both well-established, developed nations and expanding, emerging economies worldwide. The fund also has the flexibility to invest in a variety of other financial instruments, all chosen by GMO for their perceived excellent quality and strong potential for generating investor returns.
Is DRES's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.